Major Depressive Disorder and Serum Inflammatory Biomarkers as Predictors of Reward-Processing Dysfunction in an American Indian Sample.
Document Type
Article
Publication Date
9-2026
Identifier
DOI: 10.1016/j.bpsc.2025.08.015; PMCID: PMC12947981
Abstract
BACKGROUND: American Indians (AIs) experience chronic stressors that may be associated with disproportionate prevalence rates of major depressive disorder (MDD). Stress affects mental health through increased inflammatory processes and has been associated with increased risk of MDD and disruptions to reward processing. In this study, we investigated the role of inflammation in reward-processing disruptions among AI individuals with lifetime MDD, a population at heightened risk due to chronic stressors.
METHODS: Participants (N = 73) completed a monetary incentive delay task during simultaneous electroencephalography and functional magnetic resonance imaging. Blood samples were analyzed for proinflammatory (tumor necrosis factor [TNF], interleukin 6 [IL-6], C-reactive protein [CRP]) and anti-inflammatory (IL-10) biomarkers. Depression severity was assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Depression scale. Covariates were included and assessed using self-report measures.
RESULTS: Regression analyses revealed that elevated TNF concentrations and sex were associated with reduced activation across subregions of the basal ganglia during gain anticipation. Similarly, TNF and CRP concentrations, as well as medication, were associated with reduced activation within basal ganglia subregions across loss anticipation. IL-10, IL-6, and P300 showed limited predictive value for neural responses.
CONCLUSIONS: These findings suggest that inflammation may contribute to reward-processing disruptions by impairing striatal function in a sample with lifetime MDD. The observed associations underscore the importance of inflammation's potential role in and association with the pathophysiology of MDD, particularly in contexts of chronic stress. This study highlights the need to address the disproportionate mental health burden in AI communities through a biopsychosocial approach.
Journal Title
Biol Psychiatry Cogn Neurosci Neuroimaging
Volume
11
Issue
9
First Page
1051
Last Page
1061
MeSH Keywords
Humans; Major Depressive Disorder; Reward; Male; Female; Adult; Biomarkers; Magnetic Resonance Imaging; Electroencephalography; Inflammation; Interleukin-6; C-Reactive Protein; Tumor Necrosis Factor-alpha; Middle Aged; Interleukin-10; Young Adult
PubMed ID
40935332
Keywords
American Indian; Electroencephalography; Inflammatory biomarkers; Major depressive disorder; Neuroimaging; Reward anticipation
Recommended Citation
Rojas L, Mann E, Ren X, et al. Major Depressive Disorder and Serum Inflammatory Biomarkers as Predictors of Reward-Processing Dysfunction in an American Indian Sample. Biol Psychiatry Cogn Neurosci Neuroimaging. 2026;11(9):1051-1061. doi:10.1016/j.bpsc.2025.08.015


Comments
Grants and funding